Nanotechnology Therapeutics in Oncology-Recent Developments and Future Outlook

被引：7

作者：

Richardson, Paul F. ^{[1
]}

机构：

[1] Pfizer Inc, La Jolla, CA USA

来源：

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 47 | 2012年 / 47卷

关键词：

DRUG-DELIVERY; TARGETED NANOPARTICLES; CARBON NANOTUBES; PLANT-VIRUS; CANCER; DOXORUBICIN; PACLITAXEL; DESIGN; FORMULATION; PLATFORM;

D O I：

10.1016/B978-0-12-396492-2.00016-3

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：239 / 252

页数：14

共 63 条

[21] Pros and cons of the liposome platform in cancer drug targeting [J].

Gabizon, Alberto A. ;

Shmeeda, Hilary ;

Zalipsky, Samuel .

JOURNAL OF LIPOSOME RESEARCH, 2006, 16 (03) :175-183

[22] Pharmaceutical and biomedical potential of PEGylated dendrimers [J].

Gajbhiye, Virendra ;

Kumar, P. Vijayaraj ;

Tekade, Rakesh Kumar ;

Jain, N. K. .

CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (04) :415-429

[23] A review of stimuli-responsive nanocarriers for drug and gene delivery [J].

Ganta, Srinivas ;

Devalapally, Harikrishna ;

Shahiwala, Aliasgar ;

Amiji, Mansoor .

JOURNAL OF CONTROLLED RELEASE, 2008, 126 (03) :187-204

[24] pH-Responsive Nanoparticles for Drug Delivery [J].

Gao, Weiwei ;

Chan, Juliana M. ;

Farokhzad, Omid C. .

MOLECULAR PHARMACEUTICS, 2010, 7 (06) :1913-1920

[25]

GORDON KB, 1995, CANCER, V75, P2169, DOI 10.1002/1097-0142(19950415)75:8<2169::AID-CNCR2820750822>3.0.CO

[26]

2-H

[27] Albumin-bound paclitaxel: a next-generation taxane [J].

Gradishar, William J. .

EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (08) :1041-1053

[28] Microfabricated Particles for Engineered Drug Therapies: Elucidation into the Mechanisms of Cellular Internalization of PRINT Particles [J].

Gratton, Stephanie E. A. ;

Napier, Mary E. ;

Ropp, Patricia A. ;

Tian, Shaomin ;

DeSimone, Joseph M. .

PHARMACEUTICAL RESEARCH, 2008, 25 (12) :2845-2852

[29] DRUG-CARRIER POTENTIAL OF LIPOSOMES IN CANCER CHEMOTHERAPY [J].

GREGORIADIS, G ;

WILLS, EJ ;

SWAIN, CP ;

TAVILL, AS .

LANCET, 1974, 1 (7870) :1313-1316

[30] NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel [J].

Hamaguchi, T ;

Matsumura, Y ;

Suzuki, M ;

Shimizu, K ;

Goda, R ;

Nakamura, I ;

Nakatomi, I ;

Yokoyama, M ;

Kataoka, K ;

Kakizoe, T .

BRITISH JOURNAL OF CANCER, 2005, 92 (07) :1240-1246

← 1 2 3 4 5 6 7 →